Home » Authors » Jennifer Boggs

Articles by Jennifer Boggs

Alantos Raises $20M, Aims For Clinic In Osteoarthritis, Diabetes

March 10, 2005

By Jennifer Boggs

Renovis Pursuing REN-1654 In Sciatica Despite PHN Trial Data

March 9, 2005

By Jennifer Boggs

Renovis Pursuing REN-1654 In Sciatica Despite PHN Trial Data

March 9, 2005

By Jennifer Boggs

Sirtris' Series B Gets $27M For Class III HDAC Research

March 8, 2005

By Jennifer Boggs

Sirtris' Series B Gets $27M For Class III HDAC Research

March 8, 2005

By Jennifer Boggs

Neurochem Raising $61M For Alzhemed's Phase III Studies

March 7, 2005

By Jennifer Boggs

Neurochem Raising $61M For Alzhemed's Phase III Studies

March 7, 2005

By Jennifer Boggs

Allos Secures $50M Investment For Efaproxyn Phase III Program

March 4, 2005

By Jennifer Boggs

Allos Secures $50M Investment For Efaproxyn Phase III Program

March 4, 2005

By Jennifer Boggs

Osel Gains Lead Bacteria-Based Product Through Licensing Deal

March 3, 2005

By Jennifer Boggs

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 16, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 16, 2026.
SERPINB1 as potential biomarker for spinocerebellar ataxia type 2
BioWorld Science
Researchers from Goethe-Universität and collaborators investigated novel molecular biomarker candidates for spinocerebellar ataxia type 2, a progressive...
Abbvie snags PD-1/VEGF bispecific in potential $5B Remegen deal
BioWorld
With rumors regarding a couple of potential mega-mergers making the rounds, the week of the annual J.P. Morgan Healthcare Conference kicked off with the official...
JPM 2026: Year kicks off with biopharma Q4 revenue and guidance
BioWorld
It was a battle of the companies with drugs for transthyretin-mediated amyloidosis on the first day of the J.P. Morgan 2026 Healthcare Conference with Alnylam...